X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES PFIZER ALKEM LABORATORIES/
PFIZER
 
P/E (TTM) x - 33.4 - View Chart
P/BV x 6.7 5.0 134.4% View Chart
Dividend Yield % 0.6 0.8 85.2%  

Financials

 ALKEM LABORATORIES   PFIZER
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
PFIZER
Mar-17
ALKEM LABORATORIES/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,5892,055 77.3%   
Low Rs1,2321,651 74.6%   
Sales per share (Unadj.) Rs417.5429.8 97.1%  
Earnings per share (Unadj.) Rs56.373.6 76.5%  
Cash flow per share (Unadj.) Rs64.787.4 74.1%  
Dividends per share (Unadj.) Rs12.7020.00 63.5%  
Dividend yield (eoy) %0.91.1 83.4%  
Book value per share (Unadj.) Rs292.9528.7 55.4%  
Shares outstanding (eoy) m119.5745.75 261.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.44.3 78.4%   
Avg P/E ratio x25.125.2 99.5%  
P/CF ratio (eoy) x21.821.2 102.8%  
Price / Book Value ratio x4.83.5 137.4%  
Dividend payout %22.627.2 83.0%   
Avg Mkt Cap Rs m168,65384,777 198.9%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m9,1713,039 301.8%   
Avg. sales/employee Rs ThNM6,925.9-  
Avg. wages/employee Rs ThNM1,070.4-  
Avg. net profit/employee Rs ThNM1,186.3-  
INCOME DATA
Net Sales Rs m49,91519,663 253.9%  
Other income Rs m1,6451,012 162.6%   
Total revenues Rs m51,56120,674 249.4%   
Gross profit Rs m8,4823,491 243.0%  
Depreciation Rs m1,006629 159.8%   
Interest Rs m67110 6,985.4%   
Profit before tax Rs m8,4513,864 218.7%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m01,304 0.0%   
Tax Rs m1,6061,801 89.2%   
Profit after tax Rs m6,7313,368 199.9%  
Gross profit margin %17.017.8 95.7%  
Effective tax rate %19.046.6 40.8%   
Net profit margin %13.517.1 78.7%  
BALANCE SHEET DATA
Current assets Rs m27,06220,789 130.2%   
Current liabilities Rs m15,3247,870 194.7%   
Net working cap to sales %23.565.7 35.8%  
Current ratio x1.82.6 66.9%  
Inventory Days Days6760 111.3%  
Debtors Days Days4122 184.1%  
Net fixed assets Rs m12,6109,175 137.4%   
Share capital Rs m239458 52.3%   
"Free" reserves Rs m34,49023,731 145.3%   
Net worth Rs m35,02724,189 144.8%   
Long term debt Rs m1,21225 4,846.4%   
Total assets Rs m54,38732,706 166.3%  
Interest coverage x13.6403.5 3.4%   
Debt to equity ratio x00 3,346.9%  
Sales to assets ratio x0.90.6 152.7%   
Return on assets %13.610.3 131.8%  
Return on equity %19.213.9 138.0%  
Return on capital %24.921.4 116.2%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,56363 10,434.5%   
Fx outflow Rs m3,0124,067 74.1%   
Net fx Rs m3,552-4,004 -88.7%   
CASH FLOW
From Operations Rs m7,2593,288 220.8%  
From Investments Rs m1,864-2,496 -74.7%  
From Financial Activity Rs m-9,273-826 1,122.7%  
Net Cashflow Rs m-150-35 433.5%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 33.1 7.5 441.3%  
FIIs % 0.0 4.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 23.7 -  
Shareholders   68,381 85,207 80.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   VENUS REMEDIES  ORCHID PHARMA LTD  NOVARTIS  J.B.CHEMICALS  SHASUN PHARMA  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Rising Oil Prices; RBI Minutes and Top Stocks in Action Today(Pre-Open)

Indian share markets surged on Wednesday, snapping a two-day losing streak led by gains Reliance Industries and bank stocks.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jun 20, 2018 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS